TG Therapeutics Inc.

NASDAQ: TGTX
Share price (3/25/25): $42.80
Market cap (3/25/25): $6.723 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 12/31/23 FY 2023 – amended

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Charney Laurence N

Weiss Michael S

Vanguard Group Inc

News Filter

Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (Ublituximab-Xiiy) Full Year Revenue Guidance

Reports Second Quarter 2024 Financial Results and Raises BRIUMVI® (Ublituximab-Xiiy) Full Year Revenue Guidance

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Letter to shareholders

Letter to shareholders

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC